Celebrex® prevents adhesions after surgery

January 26, 2005

Painful surgical adhesions may be preventable by taking the COX-2 inhibitor Celebrex®, a common oral arthritis drug, just before and immediately after surgery, report researchers at Children's Hospital Boston. Their findings were published in the January 25 online Annals of Surgery.

Adhesions - bands of scar tissue that bind together two internal body surfaces - develop in 55 percent to more than 90 percent of patients undergoing surgery, depending on the type of operation. They are part of normal healing, but when surfaces fuse together that shouldn't, serious pain and complications can result. Adhesions are a major cause of bowel obstruction and infertility, and repeat surgery is often needed to cut through them. Unfortunately, adhesions often recur after these surgeries, and there has been no good way of preventing them.

Investigations led by Dr. Mark Puder and Dr. Arin Greene in the Department of Surgery and the Vascular Biology Program at Children's Hospital Boston tested COX-2 inhibitors in an animal model of abdominal adhesion formation. After undergoing surgery, groups of 6 to 18 mice received either COX-2 inhibitors (Celebrex or Vioxx), non-selective COX inhibitors (such as ibuprofen and aspirin) or placebo for 10 days.

"Results were dramatic," says Puder, senior investigator on the study.

At 10 days, the placebo group had obvious abdominal adhesions. Mice receiving non-selective COX inhibitors had a slight reduction in adhesions, and the COX-2 inhibitor group had a larger reduction. The greatest reduction was in the mice given Celebrex, and 6 of 11 Celebrex-treated mice (55%) were completely adhesion-free.

The researchers then observed the Celebrex, Vioxx, aspirin and placebo groups for an additional 25 days. Again, the Celebrex group had the fewest adhesions. The adhesion score (a measure of both the extent of adhesions and the difficulty of removing them) was only 1 in the Celebrex group, 5 in the Vioxx group, 8 in the aspirin group, and 11 in the placebo group.

Based on these findings, Puder is preparing to set up a multi-institutional clinical trial of Celebrex in adult surgical patients. "If Celebrex works in humans, you could give it to patients on the day of abdominal surgery and the 10 days after surgery," Puder says.

Currently, the most common method of preventing adhesions uses a barrier agent or gel to separate the abdominal surfaces and prevent them from binding together. However, these treatments can suppress the immune system, cause infection, and impair healing.

Although this study looked at abdominal adhesions, Puder believes that COX-2 inhibitors would also reduce adhesions after gynecologic and thoracic surgery, and possibly after orthopedic and plastic surgery.

COX-2 inhibitors are anti-inflammatory drugs best known for their use in arthritis. However, they also inhibit angiogenesis, or formation of blood vessels, and Celebrex also inhibits fibroblast activity, important in scar formation. These three properties make Celebrex a particularly good candidate for testing, Puder says, since adhesions are made up of inflammatory cells, blood vessels, and fibroblasts.

"If you stop each component of the adhesion, then within five days the tissue surface will get a whole new lining of mesothelial cells," Puder says. "Once these cells resurface the area, adhesions won't form."

Puder and colleagues did not set out to study adhesions. They were studying the effects of Celebrex on liver regeneration after injury to the liver. When they went to examine the livers of the mice, they noticed to their surprise that there were no adhesions, an unusual finding. So they decided to do a formal experiment.

"This was an accidental finding," Puder says. "It was just one of those lucky things."
-end-
Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults for over 100 years. More than 500 scientists, including eight members of the National Academy of Sciences, nine members of the Institute of Medicine and 10 members of the Howard Hughes Medical Institute comprise Children's research community. Founded in 1869 as a 20-bed hospital for children, Children's Hospital Boston today is a 325-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about the hospital visit: http://www.childrenshospital.org/research/

Boston Children's Hospital

Related Immune System Articles from Brightsurf:

How the immune system remembers viruses
For a person to acquire immunity to a disease, T cells must develop into memory cells after contact with the pathogen.

How does the immune system develop in the first days of life?
Researchers highlight the anti-inflammatory response taking place after birth and designed to shield the newborn from infection.

Memory training for the immune system
The immune system will memorize the pathogen after an infection and can therefore react promptly after reinfection with the same pathogen.

Immune system may have another job -- combatting depression
An inflammatory autoimmune response within the central nervous system similar to one linked to neurodegenerative diseases such as multiple sclerosis (MS) has also been found in the spinal fluid of healthy people, according to a new Yale-led study comparing immune system cells in the spinal fluid of MS patients and healthy subjects.

COVID-19: Immune system derails
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.

Immune cell steroids help tumours suppress the immune system, offering new drug targets
Tumours found to evade the immune system by telling immune cells to produce immunosuppressive steroids.

Immune system -- Knocked off balance
Instead of protecting us, the immune system can sometimes go awry, as in the case of autoimmune diseases and allergies.

Too much salt weakens the immune system
A high-salt diet is not only bad for one's blood pressure, but also for the immune system.

Parkinson's and the immune system
Mutations in the Parkin gene are a common cause of hereditary forms of Parkinson's disease.

How an immune system regulator shifts the balance of immune cells
Researchers have provided new insight on the role of cyclic AMP (cAMP) in regulating the immune response.

Read More: Immune System News and Immune System Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.